Document is current
Any future updates will be listed below
-
Authors
Dakhovnik, Alexander
Mantovani, Matilde
Knufinke, Marie
Brügger, Victoria
Pramono, Intan
Statzer, Cyril
Saravi, Babak
Demidenko, Oleksandr
Budovskaya, Yelena
Rümmelein, Claudia Bettina
Chabloz, Sophie
Ewald, Collin Y.
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (190072)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (190072)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (190072)
- License Information
-
More Information
Article History
Received: 15 April 2025
Accepted: 1 October 2025
First Online: 20 November 2025
Competing interests
: S.C. and M.M. declare the following competing interests: S.C. is a co-founder and M.M. is an employee of Avea Life AG, the owner of the Collagen Activator product studied in this research. Avea Life AG holds the patent for the formulation of Colgevity™. Avea Life AG funded this human observational study. These competing interests did not influence the study's design, data analysis, or interpretation. O.D. and Y.B. are co-founders of TruMe Inc. A.D. is a co-founder of Sydra AG. I.P. and C.B.R. are employed by Hautwerk AG. C.Y.E. declares to be a co-founder and shareholder of Avea Life AG and Lichi3 GmbH and is employed by Novartis.
